PLEASANTON, Calif. (AP) _ 10x Genomics Inc. (TXG) on Wednesday reported a loss of $42.4 million in its first quarter.
On a per-share basis, the Pleasanton, California-based company said it had a loss of 38 cents.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.
The life science technology company posted revenue of $114.5 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $113.1 million.
10x Genomics expects full-year revenue in the range of $600 million to $630 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News